ClinicalTrials.Veeva

Menu

Effect of Lidocaine Plus Dexmedetomidine Infusion on PONV

X

Xu Siqi

Status

Completed

Conditions

Dexmedetomidine
Lidocaine
Nausea and Vomiting, Postoperative

Treatments

Drug: saline IV
Drug: lidocaine and dexmedetomidine IV

Study type

Interventional

Funder types

Other

Identifiers

NCT03788018
AnqingMH

Details and patient eligibility

About

BACKGROUND: Few researches have manifested that intravenous (IV) lidocaine or dexmedetomidine decreased the incidence of postoperative nausea and vomiting (PONV). The investigators investigated whether IV lidocaine plus dexmedetomidine infusion could better reduce the incidence of PONV after laparoscopic hysterectomy.

METHODS: One hundred and twenty women with elective laparoscopic hysterectomy were randomly divided into two groups: patients in the lidocaine combined with dexmedetomidine group (LD group, n=60) received lidocaine (1.5 mg/kg loading, 1.5 mg/kg/h infusion) and dexmedetomidine (0.5 μg/kg loading, 0.4 μg/kg/h infusion) respectively. Patients in the control group (CON group, n=60) received the equal volume of saline. Primary outcome was the incidence of the first 48 h nausea, vomiting and PONV after surgery. The secondary outcomes included perioperative propofol and remifentanil consumption, postoperative fentanyl requirement, Ramsay sedation score, and bradycardia during post-anaesthesia care unit (PACU) stay.

Enrollment

60 patients

Sex

Female

Ages

40 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • American Society of Anesthesiologists (ASA) physical statusⅠand Ⅱ
  • Aged 40-55 years
  • Scheduled for elective laparoscopic hysterectomy

Exclusion criteria

  • History of allergy to local anesthetics
  • Severe respiratory disease
  • Renal or hepatic insufficiency
  • History of preoperative opioids medication and psychiatric
  • preoperative bradycardia
  • preoperative atrioventricular block
  • Subjects who experienced severe hypotension (mean arterial pressure [MAP] <60 mmHg) or bradycardia (heart rate [HR] <40 bpm), urticaria, or arrhythmia during lidocaine and dexmedetomidine infusion period

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

60 participants in 2 patient groups

Effect of IV lidocaine and dexmedetomidine on PONV
Experimental group
Treatment:
Drug: lidocaine and dexmedetomidine IV
Drug: saline IV
Effect of IV saline on PONV
Experimental group
Treatment:
Drug: lidocaine and dexmedetomidine IV
Drug: saline IV

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems